Schonfeld Strategic Advisors’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.41M | Buy |
+204,400
| New | +$1.41M | 0.01% | 1083 |
|
|
2024
Q2 | – | Sell |
-29,169
| Closed | -$275K | – | 2120 |
|
|
2024
Q1 | $275K | Sell |
29,169
-403,364
| -93% | -$3.81M | ﹤0.01% | 1499 |
|
|
2023
Q4 | $2.92M | Buy |
+432,533
| New | +$2.92M | 0.02% | 621 |
|
|
2023
Q1 | – | Sell |
-106,600
| Closed | -$776K | – | 2178 |
|
|
2022
Q4 | $776K | Buy |
106,600
+40,000
| +60% | +$291K | 0.01% | 1274 |
|
|
2022
Q3 | $539K | Buy |
66,600
+36,000
| +118% | +$291K | ﹤0.01% | 1671 |
|
|
2022
Q2 | $150K | Sell |
30,600
-9,000
| -23% | -$44.1K | ﹤0.01% | 1930 |
|
|
2022
Q1 | $936K | Buy |
39,600
+4,100
| +12% | +$96.9K | 0.01% | 970 |
|
|
2021
Q4 | $628K | Sell |
35,500
-46,600
| -57% | -$824K | 0.01% | 1086 |
|
|
2021
Q3 | $2.32M | Buy |
+82,100
| New | +$2.32M | 0.02% | 611 |
|